Intraoperative Neuromonitoring Market By Products and Services (Systems, Accessories, Services), By Source Type (Insourced Monitoring, Outsourced Monitoring), By Application (Spinal Surgery, Neurosurgery, Orthopedic Surgery, ENT Surgery, Vascular Surgery,

Intraoperative Neuromonitoring Market By Products and Services (Systems, Accessories, Services), By Source Type (Insourced Monitoring, Outsourced Monitoring), By Application (Spinal Surgery, Neurosurgery, Orthopedic Surgery, ENT Surgery, Vascular Surgery, Other surgeries), By Modality (Motor evoked potentials (MEPs), Somatosensory evoked potentials (SSEPs), Electroencephalography (EEG), Electromyography (EMG), Brainstem auditory evoked potentials (BAEPs), Visual evoked potentials (VEPs)), By End User (Hospitals, Ambulatory Surgical Centers (ASCs)): Global Opportunity Analysis and Industry Forecast, 2023-2032

The global intraoperative neuromonitoring market was valued at $4,819.15 million in 2022, and is projected to reach $8,729.3 million by 2032, registering a CAGR of 6.1% from 2023 to 2032. Intraoperative neurophysiologic monitoring (IONM) or intraoperative neuromonitoring is a technique to reduce the risk of neurological deficits after surgical procedures that involve the nervous system. IONM utilizes recordings of electrical potentials from the nervous system during surgical procedures. The use of neuromonitoring offers an opportunity to detect injuries before they become severe. Therefore, with the introduction of IONM, the risk of debilitating deficits such as muscle weakness, paralysis, hearing loss, and other loss of normal body functions are reduced.

The major factor driving the growth of the intraoperative neuromonitoring market is prevalence of chronic diseases, encompassing neurological disorders, cardiovascular conditions, and osteoarthritis. These conditions often require surgical intervention, where intraoperative neuromonitoring emerges as a pivotal tool, enhancing surgical precision and minimizing complications.  In addition, the rise in number of surgical procedures further drives the market growth. For instance, in 2022, a White Paper from Etiometry Inc., a digital health company, reported that approximately 900,000 cardiac surgeries are performed annually in the U.S., with an average increase in surgery volume of 5% per year. Further, with an aging population, the prevalence of chronic diseases is expected to soar, leading to a higher frequency of complex surgeries. This demographic shift is anticipated to be a key driver, fostering sustained market growth for intraoperative neuromonitoring as an indispensable component of advanced surgical practices.

Moreover, the presence of favorable reimbursement policies significantly contributes to the robust growth of the intraoperative neuromonitoring market. As healthcare systems acknowledge the importance of these monitoring technologies in ensuring patient safety during surgeries, supportive reimbursement frameworks incentivize healthcare providers to integrate intraoperative neuromonitoring into their practices. Reimbursement policies not only alleviate financial burdens on healthcare facilities but also encourage broader adoption, making these advanced monitoring solutions more accessible. This alignment between the benefits of intraoperative neuromonitoring and favorable reimbursement policies serves as a key catalyst, fostering a conducive environment for sustained market expansion. 

The intraoperative neuromonitoring market is segmented on the basis of products & services, source type, application, modality, end user, and region. On the basis of product & service, the market is segmented into system, accessory, and service. As per source type, the market is segmented into insourced monitoring and outsourced monitoring. Depending on application, the market is segmented into spinal surgery, neurosurgery, vascular surgery, ENT surgery, orthopedic surgery, and other surgeries. On the basis of modality, the market is segmented into motor evoked potential (MEPs), somatosensory evoked potential (SSEPs), electroencephalography (EEG), electromyography (EMG), brainstem auditory evoked potential (BAEPs), and visual evoked potential (VEPs). According to end user, market is segmented into hospitals and ambulatory surgical centers (ASCs). Region-wise, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).  

The major key players that operate in the global intraoperative neuromonitoring market are NuVasive, Inc.,Medtronic plc, Natus Medical Incorporated, inomed Medizintechnik GmbH, Nihon Kohden Corporation, Accurate Monitoring, Computational Diagnostics, Inc., SpecialtyCare, NeuroStyle Pte. Ltd, and Intranerve Neuroscience Holdings, LLC.

Key Benefits For Stakeholders

This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the intraoperative neuromonitoring market analysis from 2022 to 2032 to identify the prevailing intraoperative neuromonitoring market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the intraoperative neuromonitoring market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global intraoperative neuromonitoring market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Products and Services

Systems
Accessories
Services

By Source Type

Insourced Monitoring
Outsourced Monitoring

By Application

Spinal Surgery
Neurosurgery
Orthopedic Surgery
ENT Surgery
Vascular Surgery
Other surgeries

By Modality

Motor evoked potentials (MEPs)
Somatosensory evoked potentials (SSEPs)
Electroencephalography (EEG)
Electromyography (EMG)
Brainstem auditory evoked potentials (BAEPs)
Visual evoked potentials (VEPs)

By End User

Hospitals
Ambulatory Surgical Centers (ASCs)

By Region

North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
India
Australia
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA

Key Market Players

Medtronic plc
inomed Medizintechnik GmbH
Nihon Kohden Corporation
Accurate Monitoring
SpecialtyCare
NeuroStyle Pte.Ltd
Intranerve Neuroscience Holdings, LLC
Natus Medical Incorporated.
Computational Diagnostics, Inc.
NuVasive, Inc.

Please Note: It will take 7-10 business days to complete the report upon order confirmation.